{"podcast":{"title":"The Uromigos","slug":"the-uromigos-1214845","podcast_index_feed_id":1214845,"rss_url":"https://anchor.fm/s/13347ea8/podcast/rss","website_url":"https://www.uromigos.org","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/3122074/3122074-1626815623969-26c22e1d3574c.jpg","author":"The Uromigos","episode_count":479,"summary":"Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London","last_synced_at":"2026-07-13T22:19:20.611456+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845"},"episode":{"title":"Episode 508: ASCO 2026 Plenary - PROTEUS: ADT +/- Apalutamide in high-risk Localized Prostate Cancer","slug":"episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer","published_at":"2026-05-31T18:30:00+00:00","page_url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer","show_page_url":"https://stenobird.com/podcast/the-uromigos-1214845","url":"https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-508-ASCO-2026-Plenary---PROTEUS-ADT---Apalutamide-in-high-risk-Localized-Prostate-Cancer-e3jja7d","audio_url":"https://anchor.fm/s/13347ea8/podcast/play/120219309/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-19%2F424459091-44100-2-9da0f181e09c.m4a","summary":"Mary Ellen Taplin joins us on the heels of her ASCO 2026 Plenary presentation with this exciting phase 3 data certain to generate discussion about the landscape of high risk prostate cancer.","meta_description":"Mary Ellen Taplin joins us on the heels of her ASCO 2026 Plenary presentation with this exciting phase 3 data certain to generate discussion about the lan…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2380,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-uromigos-1214845/episode-508-asco-2026-plenary-proteus-adt-apalutamide-in-high-risk-localized-prostate-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}